Regulation - Desktop Hero

Medicines regulation

We navigate the complex landscape of pharmaceutical regulations to ensure your innovations reach the market safely and efficiently.

Empowering Innovation

Supporting the development of clients’ cutting-edge treatments through ensuring that regulatory requirements are met in a rapidly changing healthcare landscape.

Ensuring Compliance

Ensuring clients’ pharmaceutical products adhere to both legal and regulatory standards.

Trusted partner in navigating pharmaceutical regulations

Providing expert guidance, personalised support, proactive market access strategies for clients’ products.

Our team is committed to providing strategic guidance and robust support, helping you overcome regulatory hurdles and achieve your goals. We advise clients on all aspects of regulatory and compliance requirements, including:’

  • Navigation of Pharmaceutical Regulations: Guiding clients through complex regulatory frameworks. Ensuring clients adhere to national and international regulatory standards.
  • Strategic Guidance: Providing expert advice on regulatory strategies to facilitate market access. Helping clients navigate the regulatory landscape to achieve business objectives.
  • Advising on UK and EU Litigation: Providing robust legal support and representation of clients navigating pharmaceutical regulations in regulatory disputes. Acting for clients in litigation before the High Court of England & Wales as well as EU national courts and the General Court and Court of Justice in relation to enforcing and challenging regulatory exclusivities.
  • Compliance Support: Assisting in meeting all necessary legal and regulatory requirements for pharmaceutical products.
  • Risk Management: Identifying and mitigating potential regulatory risks.
  • Documentation and Submissions: Preparing and reviewing regulatory documents and submissions to competent authorities.
  • Regulatory Updates: Keeping clients informed about changes in the regulatory landscape and their implications. Ensuring clients remain compliant with evolving regulatory requirements.

 

Please select

Out-Law / Your daily need to know

Our latest work

Our advisers act on domestic and international projects of all shapes and sizes, working with many of the leading names across this diverse sector. Browse our experience below, or use the filters to look-up recent work in particular geographies and legal disciplines.

  • Client confidential

    Representing a client in proceedings brought before the General Court of the EU, seeking annulment of the European Commission’s decision to grant conditional marketing authorisation for an advanced therapy medicinal product.

  • Client confidential

    Advising a global pharmaceutical company on interpreting the new ‘affordability mechanism’ within the UK government's ABPI VPAG.

  • Client confidential

    Advised a global pharmaceutical company on the marketing authorisation application process of orphan drug exclusivity rights for a medicinal product for regulatory data protection (RDP) in the United Kingdom.

  • Teva Pharmaceutical Industries Limited

    Acted for Teva in multiple cases concerning data, market and orphan incentives before national courts, the EU General Court and CJEU.

  • Client confidential

    Advising on two separate products for a global pharmaceutical company and a biotech firm, focusing on the preparation of submissions to the European Medicines Agency to secure orphan drug exclusivity at the final review stage.

  • Accord Healthcare Limited

    Advised Accord in proceedings before the EU General Court concerning its marketing authorisation for a generic dexmedetomidine product, considering the appropriateness of a Reference Medicinal Product.

  • Client confidential

    Advising a listed biotechnology company headquartered in Switzerland on the conduct of pre-clinical and clinical studies in the field of biologically produced radiopharmaceuticals.

  • Clinuvel (UK) Ltd

    Acted for Clinuvel in its successful appeal and subsequent judicial review proceedings in the English High Court against a decision of the UK market access agency, NICE, refusing to commission its product afamelanotide (Scenesse®) for routine use in the NHS.

Our expertise, at your disposal

With over 490 partners and 3000 people around the world, we are well-placed to support you across a full range of legal and advisory services.

Gareth Morgan

Partner

Gareth advises life sciences clients on all exclusivity rights around pharmaceuticals and medical device products. Whether it is patents, SPCs or regulatory exclusivities, Gareth has decades of experience advising on these rights and has litigated in UK and EU courts.

Catherine Drew

Partner

Catherine is a patent and regulatory Life sciences & health specialist with a degree in pathology. She is based in the London, Dublin, and Belfast offices.

Managing Senior Associate

Natalie advises clients on exclusivity rights in the pharmaceutical industry, including patents, SPCs and regulatory exclusivities.

Natalie Coan profile image

Managing Senior Associate

Carly focuses on life sciences regulations, helping clients in the pharmaceutical and medical device industries with national and European cases. She handles advising, litigation, and coordination for generic medicines and research regulations, including data exclusivity and SPCs.

Carly van der Beek profile image

Latest press releases

Show me all press releases

Pinsent Masons advises US ownership group on the acquisition of Shrewsbury Town FC

Multinational law firm Pinsent Masons has advised a US investor group led by Scott Davidson on the acquisition of Shrewsbury Town FC in a deal that marks a significant new chapter in the club's proud history.

Pinsent Masons appoints Sarah Derbyshire as General Counsel

Multinational law firm Pinsent Masons has appointed Sarah Derbyshire as General Counsel.

Orbital launches Scots Law workflows for Commercial Real Estate following pilot with Pinsent Masons

Orbital has built specific workflows for Scottish commercial real estate work, built around Scots Law and Scottish real estate practice 

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.